A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)

Clinical trial NCT03599713 · COMPLETED

Trial details

NCT number: NCT03599713
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Merkel Cell Carcinoma

Start date: 2019-02-25
Primary completion: 2022-01-21
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.